These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16603610)

  • 41. Modified Measles: A Diagnostic Challenge.
    Roose J; Rohaert C; Jadoul A; Fölster-Holst R; van Gysel D
    Acta Derm Venereol; 2018 Feb; 98(2):289-290. PubMed ID: 29057422
    [No Abstract]   [Full Text] [Related]  

  • 42. Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance.
    Nelson AN; Putnam N; Hauer D; Baxter VK; Adams RJ; Griffin DE
    Sci Rep; 2017 Sep; 7(1):11474. PubMed ID: 28904342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measles immunity and immunosuppression.
    Griffin DE
    Curr Opin Virol; 2021 Feb; 46():9-14. PubMed ID: 32891958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys.
    Permar SR; Rao SS; Sun Y; Bao S; Buzby AP; Kang HH; Letvin NL
    J Infect Dis; 2007 Dec; 196(12):1784-93. PubMed ID: 18190259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of viruses with dendritic cells: a double-edged sword.
    Bhardwaj N
    J Exp Med; 1997 Sep; 186(6):795-9. PubMed ID: 9333647
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective immunity, but suppressed immune responses to third party antigens are generated in cotton rats during measles virus infection.
    Niewiesk S; Eisenhuth I; ten Meulen V
    Biochem Soc Trans; 1997 May; 25(2):355S. PubMed ID: 9191400
    [No Abstract]   [Full Text] [Related]  

  • 48. Antimeasles immunoglobulin G and virus-neutralizing activity in sera of patients with otosclerosis.
    Lolov S; Edrev G; Kyurkchiev S
    Adv Otorhinolaryngol; 2007; 65():107-113. PubMed ID: 17245030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The measles paradox explained: how measles virus both suppresses and activates the immune system].
    de Swart RL
    Ned Tijdschr Geneeskd; 2020 May; 164():. PubMed ID: 32395944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
    Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
    J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological mechanisms controlling measles virus infection.
    Cernescu C
    Virologie; 1981; 32(1):41-55. PubMed ID: 6171091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measles virus interaction with host cells and impact on innate immunity.
    Gerlier D; Valentin H
    Curr Top Microbiol Immunol; 2009; 329():163-91. PubMed ID: 19198566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.
    Lin WH; Kouyos RD; Adams RJ; Grenfell BT; Griffin DE
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14989-94. PubMed ID: 22872860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proliferative response of lymphocytes to measles virus in former measles patients and persons vaccinated with live measles vaccine].
    Tikhonova NT; Khrometskaia TM; Mamaeva TA; Azarova SA; Ignat'eva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):92-3. PubMed ID: 7245973
    [No Abstract]   [Full Text] [Related]  

  • 55. [Two different receptors for wild type measles virus].
    Tahara M; Takeda M
    Uirusu; 2011 Dec; 61(2):249-55. PubMed ID: 22916571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.
    Klingele M; Hartter HK; Adu F; Ammerlaan W; Ikusika W; Muller CP
    J Med Virol; 2000 Sep; 62(1):91-8. PubMed ID: 10935994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current animal models: transgenic animal models for the study of measles pathogenesis.
    Sellin CI; Horvat B
    Curr Top Microbiol Immunol; 2009; 330():111-27. PubMed ID: 19203107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles pathogenesis, immune suppression and animal models.
    Laksono BM; de Vries RD; Duprex WP; de Swart RL
    Curr Opin Virol; 2020 Apr; 41():31-37. PubMed ID: 32339942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of measles virus infection: an hypothesis for altered immune responses.
    Griffin DE; Ward BJ; Esolen LM
    J Infect Dis; 1994 Nov; 170 Suppl 1():S24-31. PubMed ID: 7930750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel mechanism of immunosuppression after measles.
    Starr SE
    Lancet; 1996 Nov; 348(9037):1257-8. PubMed ID: 8909375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.